Taken together, CYH33 not only inhibited the phosphorylation of Akt but also attenuated the membrane localization and phosphorylation of GAB1, resulting in reduced PI3K and MAPK signaling and ultimately inhibiting the proliferation of HNSCC cells in vitro and in vivo. The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.